- $2.42bn
- $3.32bn
- $2.32bn
- 78
- 40
- 76
- 70
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,072 | 1,652 | 1,820 | 1,991 | 2,319 |
Cost of Revenue | |||||
Gross Profit | 269 | 276 | 313 | 370 | 442 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,031 | 1,587 | 1,715 | 1,857 | 2,219 |
Operating Profit | 41.3 | 65 | 105 | 133 | 99.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 30.4 | 64.5 | 105 | 121 | 58.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 24.8 | 46.3 | 78.5 | 89.8 | 46.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4.4 | 35.8 | 78.7 | 90.2 | 46.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.3 | 35.4 | 78.1 | 89.1 | 45.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.97 | 1.02 | 2.25 | 2.54 | 1.96 |
Dividends per Share |